Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PER2 | O15055 | 6/20 | 0.36 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21389244 | 0.90 | MITF (0.36) | PER2CRY2MAPK1 | |
| SCHEMBL24796422 | 0.90 | MITF (0.36) | PER2CRY2MAPK1 | |
| SCHEMBL24796340 | 0.86 | CYP1A2 (0.35) | PER2CRY2OPRM1OPRD1 | |
| SCHEMBL21389454 | 0.86 | HPGD (0.42) | — | |
| SCHEMBL24796055 | 0.86 | CYP1A2 (0.35) | PER2CRY2OPRM1OPRD1 | |
| SCHEMBL24796057 | 0.75 | SMN1; SMN2 (0.32) | — | |
| SCHEMBL21389271 | 0.72 | P2RX7 (0.33) | — | |
| SCHEMBL24796301 | 0.70 | HSD17B10 (0.35) | — | |
| SCHEMBL21389312 | 0.68 | ALDH1A1 (0.34) | MAPK1 | |
| SCHEMBL21389449 | 0.68 | ALDH1A1 (0.34) | MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11535660-B1 | Modulators of G-protein coupled receptors | Cannot Therapeutics, Inc. (US) | 2022-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11535660-B1 | Modulators of G-protein coupled receptors | GIPR, GLP1R, GCGR | PER2 2034/4885CRY2 2693/4885OPRM1 449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.